Investor and operator focused on European growth-stage technology and fintech companies. Mathieu Cornu has experience in corporate development, strategic partnerships and scaling go-to-market functions across B2B software and digital payments. Known for hands-on portfolio support, deal sourcing in cross-border markets, and advising on fundraising and commercial scaling for venture and growth capital investors.
Investor and operator focused on European growth-stage technology and fintech companies. Mathieu Cornu has experience in corporate development, strategic partnerships and scaling go-to-market functions across B2B software and digital payments. Known for hands-on portfolio support, deal sourcing in cross-border markets, and advising on fundraising and commercial scaling for venture and growth capital investors.
Deploys a growth-stage, operator-led investment approach targeting European technology and fintech companies, prioritizing scalable B2B software and digital payments. Focuses on commercial acceleration and cross-border expansion, allocating capital alongside active strategic partnership and GTM scaling support. Underwrites opportunities with emphasis on unit economics, repeatable sales motions, and founder alignment; favors concentrated, hands-on positions with multi-year horizons and staged risk management tied to commercial milestones.
Deploys a growth-stage, operator-led investment approach targeting European technology and fintech companies, prioritizing scalable B2B software and digital payments. Focuses on commercial acceleration and cross-border expansion, allocating capital alongside active strategic partnership and GTM scaling support. Underwrites opportunities with emphasis on unit economics, repeatable sales motions, and founder alignment; favors concentrated, hands-on positions with multi-year horizons and staged risk management tied to commercial milestones.
| Trades 19957 | Longs Won 12473/19957 62% | Profit Factor 5.64 |
| Profitability | Shorts Won 0/0 0% | Standard Deviation $29.46M |
| Average Win $4.76M | Best Trade (Oct 19) $2.46B | Sharpe Ratio -11.15 |
| Average Loss -$1.41M | Worst Trade (Oct 19) -$210.28M | Z-Score 9.72 (100%) |
| Commissions $0 | Avg. Trade Length 1y 5m 3w 2d | Expectancy $2.45M |
| Loss Size | 100% | 90% | 80% | 70% | 60% | 50% | 40% | 30% | 20% | 10% |
| Probability of Loss | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% | <0.01% |
| Consecutive Losing Trades | 76,923 | 69,231 | 61,538 | 53,846 | 46,154 | 38,462 | 30,769 | 23,077 | 15,385 | 7,692 |
| Symbol | Quantity | Cost | Value | Comm. | Profit ($) | Gain (%) | Change |
|---|---|---|---|---|---|---|---|
A Agilent Technologies Inc. | 4.49M | $534.08M | $769.02M | - | $234.94M | 43.99% | -1.075% |
AA Alcoa Corporation | 40,725 | $1.55M | $1.68M | - | $127,562.37 | 8.22% | -0.495% |
AAL American Airlines Group Inc. | 25,509 | $310,794.07 | $303,046.92 | - | -$7,747.15 | -2.49% | 0.0 |
AAMI Acadian Asset Management Inc. | 4,343 | $153,905.88 | $408,459.15 | - | $254,553.27 | 165.4% | +2.051% |
AAOI Applied Optoelectronics, Inc. | 11,574 | $665,377.91 | $910,063.62 | - | $244,685.71 | 36.77% | +4.049% |
AAON Aaon Inc. | 883,740 | $79.38M | $66.32M | - | -$13.06M | -16.46% | +1.777% |
AAP Advance Auto Parts Inc. | 9,283 | $448,297.1 | $412,350.86 | - | -$35,946.24 | -8.02% | -0.067% |
AAPL Apple Inc. | 8.75M | $1.57B | $2.99B | - | $1.43B | 90.96% | -0.444% |
AAUC Allied Gold Corporation | 21,381 | $444,851.6 | $450,711.48 | - | $5,859.88 | 1.32% | +0.765% |
ABBV AbbVie Inc. | 909,328 | $156.45M | $258.16M | - | $101.71M | 65.01% | -0.533% |
ABCB Ameris Bancorp | 10,464 | $497,419.65 | $828,539.52 | - | $331,119.87 | 66.57% | -0.677% |
ABG Asbury Automotive Group Inc. | 2,821 | $652,380.36 | $480,359.88 | - | -$172,020.48 | -26.37% | +0.135% |
ABM ABM Industries Inc. | 11,006 | $462,774.78 | $567,524.39 | - | $104,749.61 | 22.64% | +0.811% |
ABNB Airbnb, Inc. | 185,526 | $25.67M | $32.35M | - | $6.68M | 26.02% | +0.386% |
ABR Arbor Realty Trust Inc. | 35,719 | $479,504.65 | $92,512.21 | - | -$386,992.44 | -80.71% | -3.717% |
ABT Abbott Laboratories | 758,530 | $90.59M | $78.8M | - | -$11.79M | -13.01% | -0.953% |
ABUS Arbutus Biopharma Corporation | 23,927 | $88,156.32 | $100,014.86 | - | $11,858.54 | 13.45% | -0.948% |
ABVX Abivax SA ADR | 492,068 | $60.57M | $43.62M | - | -$16.95M | -27.98% | +0.584% |
ACA Arcosa Inc. | 6,953 | $585,202.76 | $1.02M | - | $437,235.89 | 74.72% | -0.007% |
ACAD Acadia Pharmaceuticals Inc. | 1.98M | $44.57M | $38.78M | - | -$5.79M | -12.99% | +2.275% |